What is L-Nutra?
L-Nutra operates at the intersection of biotechnology and nutrition, positioning itself as a leader in the emerging field of nutri-technology. The company specializes in developing precision nutrition programs that are grounded in cellular longevity science, designed to promote healthier aging and mitigate the impact of chronic health conditions. By collaborating with prestigious global research institutions, L-Nutra has built a robust portfolio of patented therapies that bridge the gap between traditional dietary habits and medical-grade health interventions. Its market position is defined by a commitment to clinical rigor, ensuring that every product offering is backed by extensive research and therapeutic efficacy, thereby setting a new standard for how nutrition is utilized in modern healthcare.
How much funding has L-Nutra raised?
L-Nutra has raised a total of $83.8M across 2 funding rounds:
Debt
$350K
Series D
$83.5M
Debt (2020): $350K with participation from PPP
Series D (2026): $83.5M led by Mubadala Investment Company, Stéphane Bancel, Brentwood Associates, and 618 Ventures
Key Investors in L-Nutra
Mubadala Investment Company
Mubadala is a global sovereign investor based in Abu Dhabi, focused on creating sustainable financial returns and fostering a diversified, globally integrated economy.
Brentwood Associates
Brentwood Associates is a growth-oriented private equity firm that partners with exceptional leadership teams to enhance essential services and drive category leadership.
618 Ventures
618 Ventures is an early stage venture capital firm specializing in technologies that transform human health, including personalized medicine and intelligent prevention.
What's next for L-Nutra?
With the successful closure of this major enterprise-level funding, L-Nutra is poised to enter a period of aggressive operational scaling and product diversification. The strategic roadmap likely includes the expansion of its medical nutrition therapy pipeline and the further integration of its longevity-focused programs into mainstream clinical practice. By utilizing this capital to strengthen its research infrastructure and distribution networks, the company aims to solidify its category leadership in the healthspan sector. Future efforts will likely focus on deepening its collaboration with healthcare providers to integrate precision nutrition into standard patient care protocols, ultimately driving long-term value for stakeholders and improving health outcomes on a global scale.
See full L-Nutra company page
